Opioid Safety and Glycemic Control Management

SUMMARY

Opioid Safety and Glycemic Control training sessions offers the latest information on clinical best practices in from national experts. The program provides in-person training sessions presented by expert faculty, topic-specific webinars, downloadable resources, and an interactive discussion forum through Hospital Medicine Exchange (HMX), enabling participants to ask questions and learn the most relevant answers. 

GOAL

To educate participants on opioid safety and glycemic control by emphasizing the use of best practices through training and resources.

TARGET AUDIENCE

Diabetes educators, clinical educators, clinical nutritionists, physician and nursing leadership, pharmacists, hospitalists, intensivists, frontline caregivers, information technology specialists, quality improvement.

LEARNING OBJECTIVES

After completing the module, the participant will demonstrate the ability to:

  1. Address patient pain in the acute setting through a comprehensive and holistic approach
  2. Identify the high-risk patient and utilize system based strategy to produce the risk of unintended harm from opioids
  3. Utilize alternatives to opioids for inpatient pain control
  4. Identify glycemic targets in critical care and non-critical care settings
  5. State criteria for initiating and intensifying insulin therapy using algorithms
  6. Use transition algorithm to develop an individualized diabetes discharge regimen based on A1c
CME INFORMATION

Accreditation Statement:
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:
The Society of Hospital Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 CreditTM.  Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Non-physician
Course opens: 
04/27/2017
Course expires: 
05/10/2020
Non-member cost:
$0.00
Rating: 
0

Albany, May 10, 2017
Syracuse, May 11, 2107
Buffalo, May 12, 2017
Nassau, May 22, 2017
New York City, May 23, 2017

Matthew Jared, MD

Matt Jared reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Jane Seley, DNP, MPH, MSN, BC-ADM, CDE

Jane Seley reports the following:

  1. Consulting:
    1. Johnson & Johnson Diabetes Institute (JJDI)
    2. Bayer Diabetes
  2. Advisory Committee/Board
    1. Boehringer-Ingelheim/Lilly Alliance
    2. Sanofi Diabetes
    3. Novonordisk
    4. Abbott Nutrition

Naina Sinha Gregory, MD  

Naina Sinha Gregory reports having no relevant financial or advisory relationships with corporate organizations related to this activity.                  

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Non-physician

Accreditation Period

Course opens: 
04/27/2017
Course expires: 
05/10/2020

Price

Non-member cost:
$0.00
Please login or register to take this course.